Investment Summary |
|
---|---|
Date | 2022-06-02 |
Target | Vernal Biosciences |
Sector | Life Science |
Investor(s) | Ampersand Capital Partners |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1988 |
PE ASSETS | 2.0B USD |
Size | Large |
Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 69 of 79 |
Sector (Life Science) | 34 of 39 |
Type (Venture) | 11 of 11 |
State (Vermont) | 1 of 1 |
Country (United States) | 59 of 65 |
Year (2022) | 4 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-04-18 |
Syft
Christchurch , New Zealand Syft develops SIFT-MS, a form of direct mass spectrometry that analyses volatile organic compounds (VOCs) in the air with typical detection limits at parts-per-trillion level (by volume; pptv). Syft was founded in 2002 and is based in Christchurch, New Zealand. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-23 |
Sterling Medical Devices
Moonachie, New Jersey, United States Sterling Medical Devices is a provider of custom electromechanical and software solutions for the medical device industry. Sterling Medical Devices was founded in 1998 and is based in Moonachie, New Jersey. |
Buy | - |